XML 73 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of non-vested restricted share
Non-vested share units as of January 1, 2022   277,173 
Granted   
-
 
Vested   (269,175)
Forfeited   (7,998)
Non-vested share units as of December 31, 2022   
-
 

 
Schedule of non-vested restricted share
Non-vested share units as of October 23, 2020 
 
 
Granted   100,000 
Vested   (16,667)
Non-vested share units as of December 31, 2020   83,333 
Vested   (33,334)
Non-vested share units as of December 31, 2021   49,999 
Vested   (33,334)
Non-vested share units as of December 31, 2022   16,665 

 
Schedule of the stock option activity
   Number of
Shares		   Average
Exercise Price
per Share		   Aggregate
Intrinsic
Value*		   Weighted
Average
Remaining
Contractual
Term in
Years		 
                 
Outstanding at January 1, 2022   2,750,002    1.96    
       -
    5.7 
Exercisable at January 1, 2022   
-
    
-
   $
-
    
-
 
                     
Granted   -    
-
    
-
    
-
 
Exercised   
-
    
-
    
-
    
-
 
Forfeited   (549,958)   1.96    
-
    - 
Outstanding at December 31, 2022   2,200,044   $1.96   $
-
    4.7 
Exercisable at December 31, 2022   549,958   $1.96   $
-
    4.7 

 

* The intrinsic value of the stock options at December 31, 2022 is the amount by which the market value of the Company’s common stock of $0.99 as of December 31, 2022 exceeds the average exercise price of the option. As of December 31, 2022, the intrinsic value of the outstanding and exercisable stock options was $nil.